There is another reason not to use Ozempic. New research from British scientists shows that the use of the drug could change a person’s personality, something called impulse control disorders. This can lead to problems in your relationships.
The research was led by Professor Raymond Playford, an expert in molecular medicine at the University of West London. He told the Daily Mail, “The potential associations we have come across have mainly related to changing personal relationships, such as divorce or splitting up from what seemed to be stable relationships and changing their home situation such as moving house on short notice.”
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Ozempic is a brand name for a prescription medication called semaglutide. It is injected once weekly and is FDA-approved to treat type 2 diabetes in adults, along with diet and exercise. While Ozempic may cause weight loss as a side effect, it is not FDA-approved for this purpose. There is a different medication with a higher dosage of semaglutide called Wegovy that is specifically approved for weight loss. It works by increasing the amount of insulin your body produces and by decreasing the amount of sugar your liver makes.
Impulse control disorders (ICDs) are a group of mental health conditions characterized by difficulty resisting urges to act on impulses, even when those actions could have negative consequences. People with ICDs often experience intense urges or cravings that they feel powerless to resist. These urges can lead to behaviors that can be harmful to themselves or others.
ICD can be caused by a variety of factors, including genetics, brain chemistry, and environmental factors. Treatment for ICD typically involves a combination of therapy and medication. Cognitive behavioral therapy (CBT) can help people with ICDs identify and change their thought patterns and behaviors. Medication can also be helpful in some cases, such as for treating co-occurring conditions like anxiety or depression.
So, the experts want to see additional warnings added to drugs like Ozempic.
“We are advising that doctors also warn patients to look out for urges that are ‘out of character’ or unusual with cost or personal repercussions — for instance divorce — and to ‘step back’ and think whether this is a sensible decision,” Dr. Playford said.
